Earnings Feed
Start Free
REGENERON PHARMACEUTICALS, INC.·4

Dec 10, 4:03 PM ET

Pitofsky Jason 4

4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2024

Insider Transaction Report

Form 4
Period: 2024-12-06
REGENERON PHARMACEUTICALS, INC.REGN
Pitofsky Jason
SVP Controller
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2024-12-06+3,236→ 3,236 total
    Exercise: $771.64Exp: 2034-12-06→ Common Stock (3,236 underlying)
  • Award

    Common Stock

    2024-12-06+907→ 5,111 total
  • Gift

    Common Stock

    2024-04-04+89→ 89 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2024-12-09$787.00/sh−149$117,263→ 4,962 total
  • Gift

    Common Stock

    2024-04-29+90→ 179 total(indirect: By Trust)
Holdings

  • Common Stock

    (indirect: By 401(k))
    11
Footnotes (2)
  • [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
  • [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT